Form CORRESP - Correspondence:
SEC Accession No. 0001193125-23-301171
Filing Date
2023-12-21
Accepted
2023-12-21 16:00:27
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 4193
  Complete submission text file 0001193125-23-301171.txt   5294
Mailing Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000
Business Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000 01161298780088
KAZIA THERAPEUTICS LTD (Filer) CIK: 0001075880 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)